We are transforming
women’s health with
salivary RNA and IA.
Ziwig is redefining biological diagnostic standards by using AI to identify RNA expressions linked to diseases, using a simple saliva sample.
Our mission
At Ziwig, we are committed to transforming women’s health around the world through our fundamental research and the development of innovative diagnostics based on salivary RNA. We believe that scientific rigour, innovation and improved service for everyone are the driving forces behind what we do.
Founded on a unique synergy between molecular biology and AI, innovation and industrial application, Ziwig’s mission is to transform science into concrete and simple solutions at the service of life, by combining fundamental research and operational excellence.
Available in France from 2024 !
Ziwig Endotest®
The saliva test to diagnose endometriosis that gives a reliable result in just a few days.
A revolutionary approach
Our revolutionary approach, illustrated by Ziwig Endotest®, the first in vitro diagnostic medical device for endometriosis based on a saliva sample, is the result of a deep understanding of molecular biology and the exploitation of advances in artificial intelligence.
Discover
An ecosystem approach
It is also the fruit of an ecosystem approach with our Ziwig R&D laboratory located at the Institut du Cerveau – Pitié-Salpêtrière and a state-of-the-art industrial production capacity, Ziwig Lab, which analyses up to 4500 samples per week, marking a new era in the early diagnosis of endometriosis and other pathologies.
An ambitious clinical research programme
In our quest to turn science into real solutions for women’s health, we are exploring novel biological mechanisms and targeting a wide range of transcriptomic profiles to define biomarkers for a variety of diseases. This leads us to conduct rigorous clinical trials designed to transform our scientific discoveries into real advances in women’s health.
The future of women’s health in our hands
Driven by a sense of purpose and a desire to make a real difference to people’s lives, we are developing innovative women’s health solutions, using artificial intelligence and next-generation sequencing to diagnose, anticipate and, tomorrow, treat the main female pathologies with the utmost precision.
“At Ziwig, we believe that women’s health is not a niche, but a global priority. Our mission: to create disruptive innovations using the best of molecular biology, technology and AI to serve every woman. Because taking care of half of humanity means taking care of everyone.”
Yahya El Mir
President and founder of Ziwig
- Ziwig Endotest® is an in vitro diagnostic device for professional use in the diagnosis of endometriosis using a saliva sample.
- Ziwig Endotest® is an innovative diagnostic method based on the analysis of salivary miRNA and the identification of phenotypic profiles characteristic of endometriosis identified by NGS (next-generation sequencing) and modelled by AI.
- This in vitro diagnostic medical device is a regulated health product and, in accordance with these regulations, bears the CE mark.
Please read the information supplied with Ziwig Endotest® carefully. Manufacturer: Ziwig. Last update : 09/2024 - Ziwig Endotest® has obtained CE certification from a notified body (2797).
Stay connected
Sign up to be notified of the latest news and publications.
